Lorena Benedetti

Medicine · Health Sciences

15h-index1.3kcitations42works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone and Dental Protein Studies(14), Cancer Immunotherapy and Biomarkers(8), Cancer Research and Treatments(8), Medical Imaging Techniques and Applications(7), Immune Cell Function and Interaction(7)

Publications42 total

Supplementary Figure Legend from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Supplementary Figures from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Supplementary Materials and Methods from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Supplementary Tables from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Data from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Supplementary Materials and Methods from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Data from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Supplementary Figures from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Supplementary Tables from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Supplementary Figure Legend from Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
2023Open Access
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts
Gastroenterology·2021· 129 citedOpen Access
Immunogenomic profile of colorectal cancer response to immune checkpoint blockade
2020· 2 citedOpen Access
Immunogenomics of colorectal cancer response to immune checkpoint blockade: TCRseq
Zenodo (CERN European Organization for Nuclear Research)·2020Open Access
Immunogenomics of colorectal cancer response to immune checkpoint blockade: TCRseq
Zenodo (CERN European Organization for Nuclear Research)·2020Open Access
Immunogenomics of colorectal cancer response to immune checkpoint blockade: TCRseq
Zenodo (CERN European Organization for Nuclear Research)·2020Open Access
Immunogenomics of colorectal cancer response to immune checkpoint blockade: Imaging Mass Cytometry
Zenodo (CERN European Organization for Nuclear Research)·2020Open Access
Immunogenomics of colorectal cancer response to immune checkpoint blockade: Imaging Mass Cytometry
Zenodo (CERN European Organization for Nuclear Research)·2020Open Access
Identification of non-cancer cells from cancer transcriptomic data
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms·2019· 10 citedOpen Access
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma
Nature Communications·2019· 44 citedOpen Access
Patient-specific detection of cancer genes reveals recurrently perturbed processes in esophageal adenocarcinoma
2018· 4 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Osvaldo L. Podhajcer(21), Andrea S. Llera(17), Edgardo Salvatierra(15), Francesca D. Ciccarelli(13), Elmer A. Fernández(13), Alicia Bravo(13), Leandro N. Güttlein(13), Cristóbal Fresno(12), Raúl G. Spallanzani(12), Sabrina F. Mansilla(12), Cecilia Rotondaro(12), Ximena L. Raffo Iraolagoitia(12), Vanesa Gottifredi(12), Norberto W. Zwirner(12), Damjan Temelkovski(9), Michele Bortolomeazzi(8), Mohamed Reda Keddar(8), Manuel Rodriguez‐Justo(8), Jo Spencer(8), Lucia Montorsi(7)